LGNZZ — LIGAND PHARMACEUTICALS INC

—
Nasdaq · Health Care · Pharmaceuticals · CIK 886163 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 63,693,000 55,596,000 8,591,000 48,508,000 2,185,875,000 1,006,702,000 1,218,359,000
Mar 2026 51,722,000 43,625,000 17,368,000 -13,345,000 1,532,105,000 115,077,000 534,783,000
Sep 2025 115,461,000 107,364,000 54,931,000 117,273,000 1,476,772,000 139,376,000 526,601,000
Jun 2025 47,627,000 39,369,000 8,444,000 4,847,000 948,604,000 67,669,000 120,075,000

Yahoo Snapshot (yfinance, live)

Total Revenue
$306,899,008
EBITDA
$117,036,000
Free Cash Flow
$139,748,880
Enterprise Value
—
Total Cash
$447,395,008
Total Debt
$1,128,216,960
Shares Out
—
Trailing EPS
—
Book Value
$48.57
ROE
5.4%
ROA
2.8%
Div Yield
—

Annual Trend (SEC EDGAR, last 10y)

Revenues vs Net Income (last 10y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 268,087,000 41,002,000 124,453,000 1,560,637,000 543,425,000 1,017,212,000 —
Dec 2024 167,133,000 -22,606,000 -4,032,000 941,774,000 111,335,000 830,439,000 —
Dec 2023 131,314,000 11,942,000 52,154,000 787,216,000 86,303,000 700,913,000 —
Dec 2022 196,245,000 3,037,000 -33,361,000 762,668,000 165,183,000 597,485,000 —
Dec 2021 277,133,000 78,895,000 57,138,000 1,297,590,000 476,431,000 821,159,000 —
Dec 2020 186,419,000 25,845,000 -2,985,000 1,362,285,000 652,760,000 709,525,000 —
Dec 2019 120,282,000 807,076,000 629,302,000 1,494,915,000 727,683,000 767,232,000 —
Dec 2018 251,453,000 163,727,000 143,321,000 1,260,803,000 699,889,000 560,914,000 —
Dec 2017 141,102,000 68,076,000 12,556,000 671,021,000 252,374,000 399,788,000 —
Dec 2016 108,973,000 43,885,000 -1,636,000 601,585,000 230,732,000 341,290,000 —

TTM Snapshot

Revenues TTM
$290,542,000
NetIncome TTM
$197,220,000
OpCashFlow TTM
—
Assets (Latest)
$2,185,875,000
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
LLY ELI LILLY & Co $1.26T $1415.55 —
JNJ JOHNSON & JOHNSON $670.92B $278.70 —
ABBV AbbVie Inc. $517.59B $292.82 —
MRK Merck & Co., Inc. $353.44B $143.37 —
NVS NOVARTIS AG $302.46B $159.13 —

News headlines (Yahoo Finance, 1h cache)

Oracle upgraded, Reddit downgraded: Wall Street's top analyst calls
2026-11-02 14:55 · Yahoo
Ligand Pharmaceuticals Sees Strong Royalty Growth Ahead of Investor Day, Oppenheimer Says
2026-10-30 17:12 · Yahoo
Ligand Pharmaceuticals (LGND) Stock Price Ignores Q3 Earnings Losses And Royalty Strength
2026-10-30 17:09 · Yahoo
Ligand (LGND) Q3 2026 Earnings Call Transcript
2026-10-30 14:46 · Yahoo
Ligand Pharmaceuticals Incorporated Q3 2026 Earnings Call Summary
2026-10-30 12:30 · Yahoo
What Ligand Pharmaceuticals (LGND) Said on Its Q3 Earnings Call
2026-10-29 19:14 · Yahoo
Ligand: Q3 Earnings Snapshot
2026-10-29 11:20 · Yahoo
Ligand Reports Third Quarter 2026 Financial Results
2026-10-29 11:00 · Yahoo
Ligand to Participate in November Investor Conferences
2026-10-27 20:01 · Yahoo
Ligand to Host Investor Day on December 8, 2026
2026-10-22 20:01 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.